Wei T. Ho

Singapore, Singapore

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Corrigendum: Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer.

Corrigendum: Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer.

Journal: Genome research
Published: February 03, 2026

Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidence.

Mutational Signatures and Clonal Hematopoiesis in Intestinal Metaplasia across Countries with Varying Stomach Cancer Incidence.

Journal: Cancer discovery
Published: May 07, 2025

Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.

Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.

Journal: Gut
Published: December 27, 2024

Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.

Spatial profiling of patient-matched HER2 positive gastric cancer reveals resistance mechanisms to targeted therapy.

Journal: Gut
Published: December 27, 2024

Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution.

Spatially Resolved Tumor Ecosystems and Cell States in Gastric Adenocarcinoma Progression and Evolution.

Journal: Cancer discovery
Published: May 03, 2024

Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer.

Machine learning identifies activation of RUNX/AP-1 as drivers of mesenchymal and fibrotic regulatory programs in gastric cancer.

Journal: Genome research
Published: September 26, 2023

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression.

Spatiotemporal genomic profiling of intestinal metaplasia reveals clonal dynamics of gastric cancer progression.

Journal: Cancer cell
Published: March 17, 2023

Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.

Comprehensive molecular phenotyping of ARID1A-deficient gastric cancer reveals pervasive epigenomic reprogramming and therapeutic opportunities.

Journal: Gut
Published: July 21, 2022

Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.

Regulatory enhancer profiling of mesenchymal-type gastric cancer reveals subtype-specific epigenomic landscapes and targetable vulnerabilities.

Journal: Gut
Published: November 03, 2021

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.

Single-Cell Atlas of Lineage States, Tumor Microenvironment, and Subtype-Specific Expression Programs in Gastric Cancer.

Journal: Cancer discovery
Published: May 28, 2021

Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.

Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.

Journal: Genome medicine
Published: March 18, 2021

Iqgap3-Ras axis drives stem cell proliferation in the stomach corpus during homoeostasis and repair.

Iqgap3-Ras axis drives stem cell proliferation in the stomach corpus during homoeostasis and repair.

Journal: Gut
Published: August 11, 2020
Showing 1-12 of 18

Last Updated: 09/26/2026